Therapy News and Research

RSS

Meditation and yoga can be a viable option for people seeking chronic pain relief

A mindfulness-based stress reduction (MBSR) course was found to benefit patients with chronic pain and depression, leading to significant improvement in participant perceptions of pain, mood and functional capacity, according to a study in the Journal of the American Osteopathic Association.

1 Oct 2020

Study reveals how ILCs develop, adapt, specialize in specific tissue environments

Specialized immune cells settle permanently in various tissues of the body and build "local task forces". Scientists from Würzburg have now discovered, how these cell populations can renew locally and can adapt to their specific environment.

1 Oct 2020

Researchers identify a potential target for small cell lung cancer

The cover for issue 39 of Oncotarget features Figure 4, "Apoptosis assay of NRXN1-targeted ADC at IC50 dose calculated by growth inhibition curves," by Yotsumoto, et al. which reported that the authors identified transmembrane proteins overexpressed specifically in SCLC with little or no expression in normal tissues and decided to focus on the cell adhesion molecule neurexin-1.

1 Oct 2020

Patients with invasive lobular carcinoma could benefit from additional adjuvant therapy

New results presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.

1 Oct 2020

Novel training reduces anger, aggression and hostile attribution bias in social conflict situations

Scientists at the Walter Reed Army Institute for Research and Army Research Laboratory have developed a computer-based training to reduce anger, reactive aggression and hostile attribution bias--the tendency to attribute hostile intent to the actions of others--in ambiguous social conflict situations.

30 Sep 2020

A detailed map of latent virus reservoir in individuals with HIV

The latent reservoir is the last bastion of HIV's resistance to a cure. But it is difficult to destroy because it is invisible: the cells in the reservoir harbor virus that is dormant, so they don't have any viral proteins on their surface that would give them away.

30 Sep 2020

NIH awards grants for using bioengineered models to improve clinical trial design

Clinical Trials on a Chip researchers plan to build and test common and rare disease models to help improve the clinical trial process.

30 Sep 2020

Research shows the validity, reliability of isokinetic strength testing of older adults with COPD and stroke

The use of isokinetic dynamometers with older adults extends far beyond orthopedics, but the reliability and responsiveness of isokinetic measures in conditions like COPD and stroke are still being evaluated, report experts in Isokinetics and Exercise Science.

30 Sep 2020

UM171 molecule saves life of young man suffering from severe aplastic anemia

In a world first, a young man suffering from severe aplastic anemia who could not be helped by standard treatments has been given a life-saving blood transplant with the made-in-Canada UM171 molecule.

30 Sep 2020

Scientists identify key molecules that mediate radioresistance in aggressive brain cancer

Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of this brain cancer.

30 Sep 2020

FUJIFILM Irvine Scientific to exclusively distribute chemically defined substrate for stem cell culture

FUJIFILM Irvine Scientific today announced that it has become the exclusive, worldwide distributor of cellnest®, a recombinant peptide attachment substrate.

From FUJIFILM Irvine Scientific 30 Sep 2020

Cancer chemotherapy changes the function of cells that repair heart injury

Cancer chemotherapy changes the function of cells that repair heart injury, researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovered.

30 Sep 2020

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

In a recent bioRxiv* preprint paper, Professor Miles W. Carroll et al. study an agonist for reducing the SARS-CoV-2's viral load. They show that prophylactic intra-nasal administration of TLR2/6 (toll-like receptor) agonist, INNA-051, reduces viral RNA in the nose and throat, in a ferret model.

30 Sep 2020

Gut bacteria may play a role in prostate cancer therapies

A new study from Lawson Health Research Institute and Western University illustrates how the gut microbiome interacts with an oral medication in prostate cancer patients, suggesting bacteria in the gut play a role in treatment outcomes.

30 Sep 2020

Novel nasal treatment could protect people from COVID-19

A novel nasal treatment developed to boost the natural human immune system to fight common colds and flu, has proved remarkably successful in reducing COVID-19 viral replication test results, released today, reveal.

30 Sep 2020

Exosomes yield regenerative benefits equivalent to hiPSC-CCs, shows study

Science has long known that recovery from experimental heart attacks is improved by injection of a mixture of heart muscle cells, endothelial cells and smooth muscle cells, yet results have been limited by poor engraftment and retention, and researchers worry about potential tumorigenesis and heart arrhythmia.

30 Sep 2020

Increased hydroxyproline levels may be associated with joint hypermobility in autistic children

A team of researchers found out that children with autistic spectrum disorder (ASD) have increased levels of the amino acid hydroxyproline.

29 Sep 2020

Australian scientists develop a nasal spray that could stop SARS-CoV-2 infection

The novel product, called INNA-051, is being developed by Ena Respiratory, and laboratory experiments have shown that it reduced viral replication by as much as 96 percent in the animal study. Spearheaded by Public Health England’s (PHE) Deputy Director, Professor Miles Carroll, the new study described the potential treatment and has been published in the open-source preprint server bioRxiv*.

29 Sep 2020

Novel immunotherapy platform can connect mussel adhesive proteins to the antibodies

Antibody-based immunotherapy is one of treatment options for cancer immunotherapy by modulating our immune system with therapeutic antibodies.

29 Sep 2020

Researchers identify cells responsible for cardiac damage repair after infarction

Researchers at Cima and the Clinica Universidad de Navarra (Spain) have led an international study identifying the cardiac cells responsible for repairing the damage to this organ after infarction.

29 Sep 2020

Therapy News and Research

Meditation and yoga can be a viable option for people seeking chronic pain relief

Study reveals how ILCs develop, adapt, specialize in specific tissue environments

Researchers identify a potential target for small cell lung cancer

Patients with invasive lobular carcinoma could benefit from additional adjuvant therapy

Novel training reduces anger, aggression and hostile attribution bias in social conflict situations

A detailed map of latent virus reservoir in individuals with HIV

NIH awards grants for using bioengineered models to improve clinical trial design

Research shows the validity, reliability of isokinetic strength testing of older adults with COPD and stroke

UM171 molecule saves life of young man suffering from severe aplastic anemia

Scientists identify key molecules that mediate radioresistance in aggressive brain cancer

FUJIFILM Irvine Scientific to exclusively distribute chemically defined substrate for stem cell culture

Cancer chemotherapy changes the function of cells that repair heart injury

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

Gut bacteria may play a role in prostate cancer therapies

Novel nasal treatment could protect people from COVID-19

Exosomes yield regenerative benefits equivalent to hiPSC-CCs, shows study

Increased hydroxyproline levels may be associated with joint hypermobility in autistic children

Australian scientists develop a nasal spray that could stop SARS-CoV-2 infection

Novel immunotherapy platform can connect mussel adhesive proteins to the antibodies

Researchers identify cells responsible for cardiac damage repair after infarction

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News